Merck Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients
Condition:   Multiple Sclerosis, Relapsing-Remitting Intervention:   Drug: Cladribine 10 mg oral tablet Sponsors:   Pontificia Universidade Católica do Rio Grande do Sul;   Merck S.A., Brazil, an affiliate of Merck KGaA, Darmstadt, Germany Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)
Condition:   Healthy Interventions:   Drug: Gleptomet 50/1000(Metformin HCl& Sitagliptin);   Drug: Janumet 50/1000(Metformin HCl& Sitagliptin) Sponsors:   Genuine Research Center, Egypt;   Eva Pharma Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2023 Category: Research Source Type: clinical trials